Author Archives: Megan Thomas

#Cell and gene therapy #Genetics #Genetics / genomics #Research

Genetic variants that impact immune cell functioning identified

New research has found that certain genetic variants that cause modified protein binding in immune cells are also seen in those at high risk of some autoimmune diseases. Scientists from the Wellcome Sanger Institute, Josep Carreras Leukaemia Research Institute in Spain, and the MRC London Institute of Medical Sciences (LMS)… Read More

#News

#Biotechnology #Cell and gene therapy #Cell therapy #Drug development #Drug discovery

ATMPS and Ori Biotech collaborate for cell and gene therapy developers

ATMPS, provider of blockchain-based “vein to vein” cell orchestration platforms for advanced therapies, and Ori Biotech, an innovator in cell and gene therapy (CGT) manufacturing platforms, have teamed up to create integration between their data platforms to support the development of advanced therapies. The partnership will result in the integration… Read More

#News

#Awards #Clinical research

Veramed achieves Best Companies accreditation

Clinical Research Organisation (CRO) Veramed has gained a three-star rating by Best Companies, showing ‘world class’ levels of employee engagement. Veramed achieved its rating due to its commitment to employee development, wellbeing and mental health programmes, a flexible work-life balance and charity initiatives to promote employee satisfaction and engagement. CEO… Read More

#News

#Drug development #Drug discovery #Research

New protein degradation centre to lead drug discovery revolution

A new translational research centre aims to bolster the University of Dundee’s drug discovery position. The Centre for Targeted Protein Degradation (CeTPD) will contain the latest facilities to allow Professor Alessio Ciulli and colleagues to expand their pioneering work in an area that has attracted billions of pounds of investment… Read More

#News

#Antibodies #Clinical trial #Covid-19 #Immunology / Virology & Vaccines

Trial begins of antibody to treat Covid-19 respiratory disease

A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalised with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes Covid-19, has begun. The Phase II trial, called the Covid-19 anti-CD14 Treatment Trial (CaTT), is… Read More

#Covid-19 #News

#Antibody #Bacteria #Drug development #Drug discovery #Research study

New model can predict how bacteria develop antibiotic resistance

Using theoretical models of bacterial metabolism and reproduction, scientists can predict the type of resistance that bacteria will develop when they are exposed to antibiotics. This has now been shown by an Uppsala University research team, in collaboration with colleagues in Cologne, Germany. The study is published in the journal… Read More

#News

#Cancer research #Drug delivery #Drug development #Drug discovery #Research

Karen Vousden wins first Women in Cancer Research award

Francis Crick Institute group leader Karen Vousden has been awarded the first Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award. This new award celebrates a researcher who has demonstrated academic excellence and achievements in the field of cancer research and who has, through leadership or by example, furthered the advancement… Read More

#Cancer Research #News

#Clinical trial #Depression #Drug development #Drug discovery #Research

Magic mushroom compound performs as well as leading antidepressant

In a small study carried out by researchers at the Centre for Psychedelic Research at Imperial College London, it was found that psilocybin, the active compound in magic mushrooms, may be at least as effective as a leading antidepressant medication in a therapeutic setting. In a rigorous trial which assessed… Read More

#News

#Biopharmaceuticals #Data #Drug development #Life sciences

Price control could cut medicine development by 88% in California

Researchers from Biocom California and the California Life Sciences Association (CLSA) have released data analysing the potential impact of international reference pricing (foreign price controls) on California’s biopharmaceutical innovation ecosystem, including investment into small company capital formation and the new drug development pipeline. The analysis shows that implementing foreign reference… Read More

#News

#Biopharma #Biotechnology #Covid-19 #Drug discovery #Laboratory data #Life sciences

From siloed to streamlined: Pharma data management is changing

Claire Hill, Head of Strategic Marketing at IDBS, explores ways in which the pharmaceutical sector can reap the benefits of an increasingly digital world. The Covid-19 pandemic pushed the process of drug development into the spotlight in a new way. The challenge for biopharmaceutical companies—to create, test, and manufacture a… Read More

#Exclusive Content #News #Opinion

#Antibiotics #Biomedical research #Drug discovery #Research

ANTRUK launches research grants programme for antibiotic resistance

Antibiotic Research UK (ANTRUK), a charity tackling bacterial antibiotic resistance, has launched its 2021 Small Research Grants / Career Development Awards scheme. This is the charity’s largest grants programme to date. The charity will be awarding one grant of up to £50,000 and six grants of up to £25,000 each. Read More

#News

#Biopharmaceutical #Biotechnology #Drug development #Drug discovery #Life sciences

Evotec collaborates with Bristol Myers Squibb to advance therapeutics

Evotec has launched beLAB2122, a US$20 million BRIDGE (Biomedical Research, Innovation & Development Generation Efficiency) collaboration with Bristol-Myers Squibb. beLAB2122 brings together academic institutions from the Rhine-Main-Neckar region of Germany with the goal of efficiently advancing first-in-class therapeutic options across all therapeutic areas and formats into investable drug discovery and… Read More

#News

#Biologics / Biotechnology #Biopharmaceutical #Drug development #Drug discovery #Life sciences

Investment helps establish animal alternative skin testing technology

A near-£1 million investment will help University of Dundee spinout company Ten Bio to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals. The investment will enable the company to progress its mission to transform the testing of new… Read More

#News

Cytometry
#Biologics / Biotechnology #Biotechnology #Drug development #Drug discovery #Flow Cytometry #High throughput screening #Podcast

DDW podcast: Flow cytometry in drug discovery

The latest free to listen to DDW podcast episode, titled Flow Cytometry in Drug Discovery, covers an article written by Urmi Roy for DDW, read aloud by Megan Thomas. This article is called “Why flow cytometry in drug discovery is a real life-saver”, in which Roy, Global Product Manager at… Read More

#News

#Cancer research #Cell and gene therapy #Cell sequencing #DNA #Genetics

Scientists discover ‘jumping’ genes can protect against blood cancers

New research has uncovered an unexpected role for so-called “jumping” genes that are a source of genetic mutations responsible for many human diseases. In the new study from Children’s Medical Centre Research Institute at UT Southwestern (CRI), scientists discovered that these DNA sequences, also known as transposons, can protect against… Read More

#Cancer Research #News

#Cancer #Cancer research #Clinical trial #Drug development #Drug discovery

Virus therapy shows promise against inoperable skin cancers

Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were unable to have their tumours surgically removed. Researchers say that the drug combination is among the first to demonstrate the potential value of a live common cold virus, a… Read More

#Cancer Research #News